Similar articles

• A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice [proceedings].

  Horton RW, Meldrum BS. Horton RW, et al. Br J Pharmacol. 1977 Nov;61(3):477P. Br J Pharmacol. 1977. PMID: 588827 Free PMC article. No abstract available.
• The role of 2-keto-4-pentenoic acid in seizures induced by allylglycine.

  Horton RW. Horton RW. Biochem Pharmacol. 1978 May 15;27(10):1471-7. doi: 10.1016/0006-2952(78)90103-x. Biochem Pharmacol. 1978. PMID: 29640 No abstract available.
• Brain and blood levels of allylglycine in mice following doses sufficient to inhibit glutamate decarboxylase.

  Taberner PV, Keen P. Taberner PV, et al. J Neurochem. 1977 Sep;29(3):595-7. doi: 10.1111/j.1471-4159.1977.tb10710.x. J Neurochem. 1977. PMID: 894313 No abstract available.
• Behavioural effects of allylglycine (2-amino-4-pentenoic acid) and 2-keto-4-pentenoic acid following focal injection into the rat cerebellum and caudate nucleus [proceedings].

  Horton RW, Jenner P, Marsden CD, Meldrum BS, Reavill C. Horton RW, et al. Br J Pharmacol. 1978 Jun;63(2):381P. Br J Pharmacol. 1978. PMID: 667460 Free PMC article. No abstract available.
• Kinetics of brain glutamate decarboxylase. Inhibition studies with N-(5'-phosphopyridoxyl) amino acids.

  Bayón A, Possani LD, Tapia R. Bayón A, et al. J Neurochem. 1977 Sep;29(3):513-7. doi: 10.1111/j.1471-4159.1977.tb10700.x. J Neurochem. 1977. PMID: 894306 No abstract available.